,

NDFS12 – BARDA Presentation: CARB-X: A Novel Non-Dilutive Partnership to Promote Innovation and Foster a Robust Antimicrobials Pipeline

Tyler Merkeley of the Biomedical Advanced Research and Development Authority (BARDA) CARB-X program talks about the novel non-dilutive partnership created to promote innovation and foster a robust antimicrobials pipeline.

 

View Slide Deck

/0 Comments/by
You might also like
NDFS17 InflammatixNDFS17 Video: Inflammatix: Our Road to Success with Non-Dilutive Funding
NDFS17 NIDDKNDFS17 Video: The NIDDK SBIR Program: An Overview
Small Business Education and Entrepreneurial Development (SEED), in the Office of the Director, at NIH, presented at the 18th Non-Dilutive Funding Summit, 2023. Director Dr. Matthew McMahonSEED at NDFS 2023, with Director Dr. Matthew McMahon
NDFS13 NINDS Presentation: Overview and Update on HHS SBIR/STTR Programs
Powered by CARB-X
NDFS17 Abalone BioNDFS17 Video: Abalone Bio’s Pathway to Granting Success
NDFS17 CDMRP Sarah FontaineNDFS17 Video: CDMRP Funding Opportunities for Neuroscience R&D
National Institute of Allergy and Infectious Disease Presentation at the 18th Non-Dilutive Funding Summit, 2023, with Dr. Natalia KruchininNIAID at NDFS 2023, with Dr. Kruchinin
0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *